Efficacy of niprisan in the prophylactic management of patients with sickle cell disease

• National Institute for Pharmaceutical Research and Development (NG)

tel qu’imprimé : Margaret Ekpeyong

• National Institute for Pharmaceutical Research and Development (NG)

tel qu’imprimé : Benedict S. Audu

• National Institute for Pharmaceutical Research and Development (NG)

• National Institute for Pharmaceutical Research and Development (NG)

tel qu’imprimé : Olubayo O. Kunle

• National Institute for Pharmaceutical Research and Development (NG)

• National Institute for Pharmaceutical Research and Development (NG)

tel qu’imprimé : Nkechi M. Enwerem

• National Institute for Pharmaceutical Research and Development (NG)

• National Institute for Pharmaceutical Research and Development (NG)

• National Institute for Pharmaceutical Research and Development (NG)

tel qu’imprimé : Babatunde Samuel

• National Institute for Pharmaceutical Research and Development (NG)

• National Institute for Pharmaceutical Research and Development (NG)